Premium
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long‐lasting imatinib discontinuation? A real life experience
Author(s) -
Ferrero Dario,
Cerrano Marco,
Crisà Elena,
Aguzzi Chiara,
Giai Valentina,
Boccadoro Mario
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13983
Subject(s) - discontinuation , imatinib , medicine , imatinib mesylate , dasatinib , chronic myeloid leukaemia , oncology , surgery , myeloid leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom